ZA739662B - Sulfamylbenzoic acids and preparation thereof - Google Patents

Sulfamylbenzoic acids and preparation thereof

Info

Publication number
ZA739662B
ZA739662B ZA00739662A ZA739662A ZA739662B ZA 739662 B ZA739662 B ZA 739662B ZA 00739662 A ZA00739662 A ZA 00739662A ZA 739662 A ZA739662 A ZA 739662A ZA 739662 B ZA739662 B ZA 739662B
Authority
ZA
South Africa
Prior art keywords
preparation
sulfamylbenzoic acids
sulfamylbenzoic
acids
Prior art date
Application number
ZA00739662A
Inventor
G Holland
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US00318213A external-priority patent/US3843662A/en
Application filed by Pfizer filed Critical Pfizer
Publication of ZA739662B publication Critical patent/ZA739662B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
ZA00739662A 1972-12-26 1973-12-21 Sulfamylbenzoic acids and preparation thereof ZA739662B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00318213A US3843662A (en) 1971-12-09 1972-12-26 2-halo-5-(substituted piperidino sulfonyl)benzoic acids

Publications (1)

Publication Number Publication Date
ZA739662B true ZA739662B (en) 1975-01-29

Family

ID=23237158

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00739662A ZA739662B (en) 1972-12-26 1973-12-21 Sulfamylbenzoic acids and preparation thereof

Country Status (11)

Country Link
JP (2) JPS4986522A (en)
AR (1) AR214849A1 (en)
AU (1) AU6366973A (en)
BE (1) BE808939R (en)
CA (1) CA1012974A (en)
DE (1) DE2363786A1 (en)
ES (2) ES421767A2 (en)
FR (1) FR2211261B2 (en)
GB (1) GB1458029A (en)
NL (1) NL7317455A (en)
ZA (1) ZA739662B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068408A1 (en) * 1980-11-10 1983-01-05 Mochida Pharmaceutical Co., Ltd. Antiviral compositions and a method for treating virus diseases
SE8203878L (en) * 1981-06-22 1982-12-23 Mochida Pharm Co Ltd VIRUS COMPOSITION
NL8220204A (en) * 1981-06-22 1983-05-02 Mochida Pharm Co Ltd NEW AMINOSULPHONYLBENZOIC ACID DERIVATIVES AND PROCESS FOR PREPARING THEREOF.
DE3732374A1 (en) * 1987-09-25 1989-04-06 Basf Lacke & Farben ZINC, LEAD AND / OR CALCIUM SALTS OF CARBONIC ACIDS AND THE USE THEREOF AS A CORROSION PROTECT
DE19941540C2 (en) * 1999-09-01 2002-08-29 Aventis Pharma Gmbh Sulfonylcarboxamides for the manufacture of medicaments for the prophylaxis or treatment of hyperlipidemia

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1122541B (en) * 1959-12-28 1962-01-25 Hoechst Ag Process for the production of sulfamyl-anthranilic acids
FR1472906A (en) * 1961-05-08 1967-03-17 Parke Davis & Co Esters of 4-halo-3-sulfamoylbenzoic acids and their production process
FR1450358A (en) * 1960-09-03 1966-06-24 Parke Davis & Co Production of new 4-halogeno-3-sulfamylbenzamides
FR1311859A (en) * 1961-09-18 1962-12-14 Soc Ind Fab Antibiotiques Sifa New sulfonamide derivatives, and method of preparation
US3565920A (en) * 1966-12-29 1971-02-23 Ciba Geigy Corp 5-sulfamyl-anthranilic acids
US3567746A (en) * 1968-07-10 1971-03-02 Pennwalt Corp N-aryl benzamides
US3700773A (en) * 1969-06-25 1972-10-24 Merck & Co Inc Substituted phenylsulfamyl salicyclic acids and derivatives thereof in the treatment of inflammation

Also Published As

Publication number Publication date
BE808939R (en) 1974-06-21
JPS5924975B2 (en) 1984-06-13
FR2211261A2 (en) 1974-07-19
CA1012974A (en) 1977-06-28
ES421767A2 (en) 1977-07-01
GB1458029A (en) 1976-12-08
JPS58170756A (en) 1983-10-07
DE2363786A1 (en) 1974-07-11
AU6366973A (en) 1975-06-19
NL7317455A (en) 1974-06-28
JPS4986522A (en) 1974-08-19
AR214849A1 (en) 1979-08-15
ES425208A1 (en) 1976-06-16
FR2211261B2 (en) 1977-04-15

Similar Documents

Publication Publication Date Title
IL48141A0 (en) New acyldiamines and their preparation
HK86679A (en) Dethiacephalosporanic acid derivatives and their preparation and use
IL41515A0 (en) 11-deoxyprostaglandin derivatives and their preparation
IL43571A0 (en) Omega-pentanorprostaglandins and their preparation
IL43589A0 (en) Novel omega-pentanorprostaglandis and their preparation
ZA734506B (en) Enzyme preparation and use thereof
IL42072A (en) Dibenzfuran and dienzothiophene deribatives
IL41227A0 (en) Substituted 1-chromonyloxy-2-hydroxy-3-phenoxypropanes and their preparation
ZA734053B (en) Phenylalkonoic acids
IL42691A (en) 15-substituted - - pentanorprostaglandins and their preparation
ZA739388B (en) Phthalides and preparation thereof
ZA734135B (en) Tri-alkoxy-cinnamoyl-amino-carbon acids
ZA739662B (en) Sulfamylbenzoic acids and preparation thereof
IL39347A (en) Benzamidoacetohydroxamic acids and their preparation
IL41380A0 (en) Preparation of 2-alkoxy-5-alkyl-sulphonyl-benzoic acids
EG10793A (en) Indole-carboxylic acid derivatives and the preparation thereof
IL48935A0 (en) 5-hydroxy-1-amino-hydantoin and its preparation
GB1405818A (en) 6beta-amino-steroids and the preparation thereof
ZA73494B (en) Benzocycloheptathiophene derivatives and their preparation
GB1404424A (en) Thiocarboxamides and preparation thereof
PH10552A (en) 1h-tetrazole-l-acetate esters and acids
IE37768B1 (en) Oxazolopyridines and thiazolopyridines
ZA735959B (en) 4-ethers of 3-amino-5-sulfamoylbenzoic acids
IL42373A0 (en) Oxaprostaglandins and their preparation
GB1408119A (en) 1-methyl-5-nitro-2-imidazolyl- thioalkanoic acids